These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 23333660

  • 21. Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine.
    Wahed M, Louis-Auguste JR, Baxter LM, Limdi JK, McCartney SA, Lindsay JO, Bloom SL.
    Aliment Pharmacol Ther; 2009 Sep 15; 30(6):614-20. PubMed ID: 19552632
    [Abstract] [Full Text] [Related]

  • 22. [The efficacy and safety of methotrexate in refractory Crohn's disease].
    Xu P, He Y, Chen Y, Chao K, Chen B, Mao R, Tang R, Zhu Z, Zeng Z, Chen M.
    Zhonghua Nei Ke Za Zhi; 2014 Mar 15; 53(3):188-92. PubMed ID: 24767205
    [Abstract] [Full Text] [Related]

  • 23. Methotrexate in Crohn's disease: results of a randomized, double-blind, placebo-controlled trial.
    Arora S, Katkov W, Cooley J, Kemp JA, Johnston DE, Schapiro RH, Podolsky D.
    Hepatogastroenterology; 1999 Mar 15; 46(27):1724-9. PubMed ID: 10430331
    [Abstract] [Full Text] [Related]

  • 24. Adherence to thiopurine treatment in out-patients with Crohn's disease.
    Bokemeyer B, Teml A, Roggel C, Hartmann P, Fischer C, Schaeffeler E, Schwab M.
    Aliment Pharmacol Ther; 2007 Jul 15; 26(2):217-25. PubMed ID: 17593067
    [Abstract] [Full Text] [Related]

  • 25. Role of methotrexate in the management of Crohn disease.
    Ravikumara M, Hinsberger A, Spray CH.
    J Pediatr Gastroenterol Nutr; 2007 Apr 15; 44(4):427-30. PubMed ID: 17414138
    [Abstract] [Full Text] [Related]

  • 26. Long-term methotrexate for Crohn's disease: safety and efficacy in clinical practice.
    Domènech E, Mañosa M, Navarro M, Masnou H, Garcia-Planella E, Zabana Y, Cabré E, Gassull MA.
    J Clin Gastroenterol; 2008 Apr 15; 42(4):395-9. PubMed ID: 18277899
    [Abstract] [Full Text] [Related]

  • 27. Methotrexate is an efficient therapeutic alternative in children with thiopurine-resistant Crohn's disease.
    Hojsak I, Mišak Z, Jadrešin O, Močić Pavić A, Kolaček S.
    Scand J Gastroenterol; 2015 Apr 15; 50(10):1208-13. PubMed ID: 25877164
    [Abstract] [Full Text] [Related]

  • 28. Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort.
    Schnitzler F, Fidder H, Ferrante M, Noman M, Arijs I, Van Assche G, Hoffman I, Van Steen K, Vermeire S, Rutgeerts P.
    Gut; 2009 Apr 15; 58(4):492-500. PubMed ID: 18832518
    [Abstract] [Full Text] [Related]

  • 29. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates.
    Ramadas AV, Gunesh S, Thomas GA, Williams GT, Hawthorne AB.
    Gut; 2010 Sep 15; 59(9):1200-6. PubMed ID: 20650924
    [Abstract] [Full Text] [Related]

  • 30. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators.
    Feagan BG, Rochon J, Fedorak RN, Irvine EJ, Wild G, Sutherland L, Steinhart AH, Greenberg GR, Gillies R, Hopkins M.
    N Engl J Med; 1995 Feb 02; 332(5):292-7. PubMed ID: 7816064
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
    Egan LJ, Sandborn WJ, Tremaine WJ.
    Am J Gastroenterol; 1998 Mar 02; 93(3):442-8. PubMed ID: 9517654
    [Abstract] [Full Text] [Related]

  • 33. Long-term outcome of patients with Crohn's disease who respond to azathioprine.
    Camus M, Seksik P, Bourrier A, Nion-Larmurier I, Sokol H, Baumer P, Beaugerie L, Cosnes J.
    Clin Gastroenterol Hepatol; 2013 Apr 02; 11(4):389-94. PubMed ID: 23142207
    [Abstract] [Full Text] [Related]

  • 34. Initiating azathioprine for Crohn's disease.
    Levesque BG, Loftus EV.
    Clin Gastroenterol Hepatol; 2012 May 02; 10(5):460-5. PubMed ID: 22330233
    [Abstract] [Full Text] [Related]

  • 35. Clinical experience of methotrexate in Crohn's disease: response, safety and monitoring of treatment.
    Parker R, Dixit A, Fraser A, Creed TJ, Probert CS.
    Postgrad Med J; 2010 Apr 02; 86(1014):208-11. PubMed ID: 20354043
    [Abstract] [Full Text] [Related]

  • 36. Mucosal healing at 3 months predicts long-term endoscopic remission in anti-TNF-treated luminal Crohn's disease.
    af Björkesten CG, Nieminen U, Sipponen T, Turunen U, Arkkila P, Färkkilä M.
    Scand J Gastroenterol; 2013 May 02; 48(5):543-51. PubMed ID: 23477356
    [Abstract] [Full Text] [Related]

  • 37. Methotrexate for the Management of Crohn's Disease in Children.
    Scherkenbach LA, Stumpf JL.
    Ann Pharmacother; 2016 Jan 02; 50(1):60-9. PubMed ID: 26511908
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. European experience with methotrexate treatment in Crohn's disease: a multicenter retrospective analysis.
    Kopylov U, Katsanos KH, van der Woude CJ, Karmiris K, Hernandez V, Odes S, Papamichael K, Koutroubakis IE, Bojic D, Kaimakliotis I, Fiorino G, Papageorgiou N, Pineda JR, Strongili K, Sanroman L, Mantzaris GJ, Jojic N, Paspatis G, Christodoulou DK, Ben-Horin S, Tsianos EV.
    Eur J Gastroenterol Hepatol; 2016 Jul 02; 28(7):802-6. PubMed ID: 26894634
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.